RU2010147918A - 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов - Google Patents

5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов Download PDF

Info

Publication number
RU2010147918A
RU2010147918A RU2010147918/04A RU2010147918A RU2010147918A RU 2010147918 A RU2010147918 A RU 2010147918A RU 2010147918/04 A RU2010147918/04 A RU 2010147918/04A RU 2010147918 A RU2010147918 A RU 2010147918A RU 2010147918 A RU2010147918 A RU 2010147918A
Authority
RU
Russia
Prior art keywords
compound
formula
methyl
pyrazol
hydroxy
Prior art date
Application number
RU2010147918/04A
Other languages
English (en)
Russian (ru)
Inventor
ХОВЕР Антони ТОРРЕНС (ES)
ХОВЕР Антони ТОРРЕНС
Мария Роса КУБЕРЕС-АЛТИСЕНТ (ES)
Мария Роса КУБЕРЕС-АЛТИСЕНТ
САНЧЕС Мария Хосе ПРЕТЕЛ (ES)
САНЧЕС Мария Хосе ПРЕТЕЛ
ГЕЛАБЕРТ Мария Магдалена БОРДАС (ES)
ГЕЛАБЕРТ Мария Магдалена БОРДАС
Original Assignee
Лабораторьос Дель Др. Эстеве, С.А. (Es)
Лабораторьос Дель Др. Эстеве, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораторьос Дель Др. Эстеве, С.А. (Es), Лабораторьос Дель Др. Эстеве, С.А. filed Critical Лабораторьос Дель Др. Эстеве, С.А. (Es)
Publication of RU2010147918A publication Critical patent/RU2010147918A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2010147918/04A 2008-04-25 2009-04-27 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов RU2010147918A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08384005A EP2113501A1 (en) 2008-04-25 2008-04-25 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors
EP08384005.8 2008-04-25

Publications (1)

Publication Number Publication Date
RU2010147918A true RU2010147918A (ru) 2012-05-27

Family

ID=39739580

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010147918/04A RU2010147918A (ru) 2008-04-25 2009-04-27 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов

Country Status (11)

Country Link
US (1) US8492425B2 (enExample)
EP (2) EP2113501A1 (enExample)
JP (1) JP2011518811A (enExample)
KR (1) KR20110006697A (enExample)
CN (1) CN102066333A (enExample)
AU (1) AU2009239906A1 (enExample)
BR (1) BRPI0910679A2 (enExample)
CA (1) CA2722256A1 (enExample)
MX (1) MX2010011674A (enExample)
RU (1) RU2010147918A (enExample)
WO (1) WO2009130331A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2361904A1 (en) * 2010-02-04 2011-08-31 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride and crystalline forms thereof
US20130143884A1 (en) * 2009-11-25 2013-06-06 Maria Rosa Cuberes-Altisent 4-[2-[ [5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl] morpholine salts
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
RS55046B1 (sr) * 2010-02-04 2016-12-30 Esteve Labor Dr 4-[2-[[5-metil-1-(2-naftalenil)-1h-pirazol-3-il]oksi]etil]morfolin hidrohlorid i solvati
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2418192A1 (en) * 2010-07-30 2012-02-15 Esteve Química, S.A. Intermediates for the preparation of 1-aryl-pyrazol-3-one compounds useful as sigma receptors inhibitors
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2426111A1 (en) * 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
EP2460519A1 (en) 2010-12-03 2012-06-06 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in bone cancer pain
EP2460804A1 (en) * 2010-12-03 2012-06-06 Laboratorios Del Dr. Esteve, S.A. 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP2818166A1 (en) * 2013-06-26 2014-12-31 Laboratorios del Dr. Esteve S.A. Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS)
AU2014364647A1 (en) 2013-12-17 2016-06-23 Laboratorios Del Dr. Esteve, S.A. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations
WO2016019288A1 (en) 2014-08-01 2016-02-04 Smart Billiard Lighting LLC Billiard table lighting and game play monitor
MA41177A (fr) * 2014-12-15 2017-10-24 Esteve Labor Dr Utilisation de ligands des récepteurs sigma dans l'arthrose
US12345406B2 (en) 2022-02-09 2025-07-01 Blake Martin Interactive LED system for enhancing billiard gameplay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase
EP2325174A1 (en) 2004-08-27 2011-05-25 Laboratorios Del. Dr. Esteve, S.A. Sigma receptor inhibitors
EP1634872A1 (en) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
EP1829875A1 (en) * 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
US8202872B2 (en) 2006-03-01 2012-06-19 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors

Also Published As

Publication number Publication date
MX2010011674A (es) 2010-11-25
BRPI0910679A2 (pt) 2015-09-29
KR20110006697A (ko) 2011-01-20
CN102066333A (zh) 2011-05-18
WO2009130331A1 (en) 2009-10-29
CA2722256A1 (en) 2009-10-29
US8492425B2 (en) 2013-07-23
EP2113501A1 (en) 2009-11-04
JP2011518811A (ja) 2011-06-30
US20110118253A1 (en) 2011-05-19
AU2009239906A1 (en) 2009-10-29
EP2285781A1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
RU2010147918A (ru) 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов
JP2011518811A5 (enExample)
RU2010121763A (ru) Производные пиридазинона и ингибиторы р2х7 рецептора
PE20191755A1 (es) Derivados de pirazol como inhibidores de malt 1
DK1689721T3 (da) Aminopyrazolderivater som GSK-3-ihibitorer
TNSN07361A1 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
RU2008145701A (ru) Производные пурина для применения в качестве агонистов аденозинового рецептора a2a
MA30709B1 (fr) Derives de pyrido (2, 3-d) pyrimidinone et leur utilisation comme inhibiteurs de pi3.
ECSP055935A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension
RU2007149317A (ru) Циклическое производное амина, содержащее замещенную алкильную группу
EA200601896A1 (ru) Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
NO20083207L (no) Inhibitorer av IAP
RU2008145704A (ru) Пуриновые производные в качестве агонистов a2a-рецептора
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
RU2009117705A (ru) Производные 2-аминокарбонилпиридина
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
RU2009119421A (ru) Производные 2-фенил-6-аминокарбонилпиримидина и их применение в качестве антагонистов тромбоцитарного рецептора адф (p2y12 рецептора)
MA34760B1 (fr) Composés et leurs utilisation
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
JP2017500321A5 (enExample)
RU2460723C2 (ru) Производные 4-(1-аминоэтил)циклогексиламина
NO20070789L (no) Nikotinreseptoragonister for behandling av betennelsessykdommer

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20130626